menu search

OM / This Could Be the Best Growth Stock Under $20 on the Market Right Now

This Could Be the Best Growth Stock Under $20 on the Market Right Now
This healthcare stock has been a loser for investors for most of the period since its IPO in 2020. However, it has massive growth prospects in an underpenetrated market. Read More
Posted: Apr 23 2023, 07:03
Author Name: The Motley Fool
Views: 111653

OM News  

After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)

By Zacks Investment Research
November 2, 2023

After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)

Outset Medical, Inc. (OM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined w more_horizontal

Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)

By Zacks Investment Research
October 17, 2023

Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)

The heavy selling pressure might have exhausted for Outset Medical, Inc. (OM) as it is technically in oversold territory now. In addition to this tech more_horizontal

Outset Medical analysts slash price objective after multiple missteps

By Proactive Investors
October 13, 2023

Outset Medical analysts slash price objective after multiple missteps

Outset Medical Inc stock was downgraded by BofA Securities analysts to ‘Underperform' from ‘Buy', and its price objective was cut to $3 per share more_horizontal

Outset Medical stock plunges on revenue hit from FDA warning letter

By Proactive Investors
October 13, 2023

Outset Medical stock plunges on revenue hit from FDA warning letter

Outset Medical Inc shares sank as much as 40% in pre-market trading on Friday after the medical technology company reported lower-than-expected prelim more_horizontal

Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade)

By Seeking Alpha
October 6, 2023

Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade)

Outset Medical, Inc. is commercializing a new hemodialysis machine for acute care and home settings. The company has reduced guidance due to pulling i more_horizontal

Outset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
August 2, 2023

Outset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to l more_horizontal

Outset Medical: Expansive TAM, Yet Profitability Remains Distant

By Seeking Alpha
July 21, 2023

Outset Medical: Expansive TAM, Yet Profitability Remains Distant

Outset Medical Inc's share price has risen by over 11% over the past year, but the company lacks a positive bottom line, making it a risky investment. more_horizontal

Why Shares of Outset Medical Are Down Monday

By The Motley Fool
July 10, 2023

Why Shares of Outset Medical Are Down Monday

Outset said it received a Warning Letter from the FDA last week. The letter raised two new concerns regarding the company's dialysis products. more_horizontal


Search within

Pages Search Results: